Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389725 · ClinicalTrials.gov registry record · NA
The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT02389725: Completed NA study, sponsored by Mayo Clinic.
NCT02389725 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02389725, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the success rates of two different tourniquets that are used when placing an IV.
Primary Outcome
Peripheral IV access success rate is defined as the number of subjects who had successful peripheral intravenous cannulation on the first attempt. An attempt was defined as a needle penetrating the surface of the subject's skin. Successful access was defined as good flow through an IV catheter with a saline flush and without subcutaneous fluid collection.
Interventions
- DEVICE blood pressure cuff
- DEVICE disposable elastic tourniquet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02389725 record still lists
NCT02389725 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which blood pressure cuff is the first listed.
NCT02389725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02389725 about?
NCT02389725 is a clinical study titled "The Effect of Two Different Tourniquet Techniques on Peripheral IV Access Success Rates". The purpose of this study is to compare the success rates of two different tourniquets that are used when placing an IV.
What is the current status of trial NCT02389725?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2015-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02389725?
The interventions under investigation include: blood pressure cuff (DEVICE), disposable elastic tourniquet (DEVICE).
Who is sponsoring clinical trial NCT02389725?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02389725's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia